Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: MTI Wireless rises on "very strong" update

17th Feb 2026 10:21

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

MTI Wireless Edge Ltd, up 15% at 59 pence, 12-month range 38p-68.5p. The Rosh Haayin, Israel-based maker of antennas for military and commercial use expects to report revenue of approximately USD51.5 million for 2025, the top of its current market guidance range of around USD50.5 million to USD51.5 million. Earnings before interest and tax growth was "very strong" at around 30% on-year, leading MTI to expect earnings per share to be "significantly ahead" of the between approximately 5.1 US cents and 5.27 cents consensus range. It also expects net cash as of December 31 to be "significantly ahead of current market expectations", at approximately USD9.4 million, compared with the approximately USD7.5 million to USD8.5 million market consensus. The company expects to announce final results in early March.

----------

OptiBiotix Health PLC, up 9.4% at 6.4 pence, 12-month range 5.85p-20.5p. The York, England-based life sciences company confirms it has no current plans to sell its shares in SkinBioTherapeutics PLC, in which it currently has a 5.64% stake. SkinBioTherapeutics shares closed down 52% on Monday, after saying it expects full-year results to be significantly below current market expectations amid an investigation into alleged misrepresentations of material information by now-former Chief Executive Stuart Ashman. OptiBiotix also confirms that it has not sold, and does not plan to sell, any ProBiotix Health PLC shares, after ProBiotix on Monday closed down 9.7% and said this drop may result from "mistaken assumptions" about its relationship with SkinBioTherapeutics. Both companies were originally formed by OptiBiotix, but they have no other commercial or operational ties. OptiBiotix notes that it has "just over" GBP1 million cash as of December 31, up on-year from GBP739,000, and does not currently need to raise more funds. "The board believes it is in the strongest position it has been in with its first-generation products and making strong progress with its second-generation products," OptiBiotix CEO Stephen O'Hara says. SkinBioTherapeutics was up 17% on Tuesday. ProBiotix traded 18% higher.

----------

AIM - LOSERS

----------

Tertiary Minerals PLC, down 11% at 0.08p, 12-month range 0.0285p-0.12p. The mineral development firm, which has projects in Zambia, the US state of Nevada, and Sweden, reports revenue of GBP200,569 for 2025, up from GBP162,658 in 2024. Pretax loss, however, widens to GBP583,916 from GBP550,934. Administration costs increase to GBP767,192 from GBP670,118. Says the outlook for its main commodities is "bullish" with copper prices "near historically high levels" and "forecast to increase", and silver having "enjoyed a significant rerating". Tertiary Minerals intends to "aggressively advance the Mushima North discovery" this year, and envisages "a number of value-adding steps as we head towards the definition of a maiden mineral resource."

----------

boohoo Group PLC, down 10% at 20.25p, 12-month range 10.4p-28.75p. The online fast fashion retailer confirms plans to raise GBP35 million in fresh equity, which it says it will use to pay down its debt and provide the increased financial flexibility to pursue its turnaround plan. Adds that it is speaking to its lending syndicate about improved covenant amendments, due to expectations of reduced leverage, and that total support for the equity raise from directors and institutional shareholders is in excess of GBP24 million. boohoo also confirms guidance for GBP50 million in adjusted earnings before interest, tax, depreciation and amortisation for the year ending February 28, which would be up 20% on-year from GBP41.6 million. Turnaround plan is "going apace", reducing boohoo's annual fixed cost exit rate to GBP135 million from GBP175 million, and the firm says it is on track to reach GBP100 million.

----------

By Emma Curzon, Alliance News reporter

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

Mti WirelessOptiBiotix HealthSkinbiotherap.Tertiary MineralsBoohoo
FTSE 100 Latest
Value10,556.17
Change82.48